316 related articles for article (PubMed ID: 24324133)
21. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
22. FHOD3 promotes carcinogenesis by regulating RhoA/ROCK1/LIMK1 signaling pathway in medulloblastoma.
Yu J; Shi W; Zhao R; Shen W; Li H
Clin Transl Oncol; 2020 Dec; 22(12):2312-2323. PubMed ID: 32447646
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
[TBL] [Abstract][Full Text] [Related]
24. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
25. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
[TBL] [Abstract][Full Text] [Related]
26. Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells.
Perry NA; Vitolo MI; Martin SS; Kontrogianni-Konstantopoulos A
Oncotarget; 2014 Sep; 5(18):8558-68. PubMed ID: 25261370
[TBL] [Abstract][Full Text] [Related]
27. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.
Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381
[TBL] [Abstract][Full Text] [Related]
28. Deficiency of the 15-kDa selenoprotein led to cytoskeleton remodeling and non-apoptotic membrane blebbing through a RhoA/ROCK pathway.
Bang J; Jang M; Huh JH; Na JW; Shim M; Carlson BA; Tobe R; Tsuji PA; Gladyshev VN; Hatfield DL; Lee BJ
Biochem Biophys Res Commun; 2015 Jan; 456(4):884-90. PubMed ID: 25529450
[TBL] [Abstract][Full Text] [Related]
29. RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo.
Alkasalias T; Alexeyenko A; Hennig K; Danielsson F; Lebbink RJ; Fielden M; Turunen SP; Lehti K; Kashuba V; Madapura HS; Bozoky B; Lundberg E; Balland M; Guvén H; Klein G; Gad AK; Pavlova T
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1413-E1421. PubMed ID: 28174275
[TBL] [Abstract][Full Text] [Related]
30. RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes.
Torsoni AS; Marin TM; Velloso LA; Franchini KG
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1488-96. PubMed ID: 15923313
[TBL] [Abstract][Full Text] [Related]
31. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly.
Orr AW; Pallero MA; Xiong WC; Murphy-Ullrich JE
J Biol Chem; 2004 Nov; 279(47):48983-92. PubMed ID: 15371459
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
33. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
34. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
[TBL] [Abstract][Full Text] [Related]
35. The glucocorticoid dexamethasone inhibits U937 cell adhesion and neutrophil release via RhoA/ROCK1-dependent and independent pathways.
Liu D; Xiong R; Chen X; Li P; Ning Y; Peng Y; Zhao Y; Yang N; Zhou Y
Cell Physiol Biochem; 2014; 33(6):1654-62. PubMed ID: 24902944
[TBL] [Abstract][Full Text] [Related]
36. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
Li D; Wang H; Ding Y; Zhang Z; Zheng Z; Dong J; Kim H; Meng X; Zhou Q; Zhou J; Fang L; Shen Q
Cancer Lett; 2018 Jun; 424():97-108. PubMed ID: 29580806
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context.
Matsubara M; Bissell MJ
Oncotarget; 2016 May; 7(22):31602-22. PubMed ID: 27203208
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma.
Turcotte S; Desrosiers RR; Beliveau R
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F338-48. PubMed ID: 14583436
[TBL] [Abstract][Full Text] [Related]
39. Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to regulate cytoskeleton and cell adhesion.
Fu L; Wang X; Yang Y; Chen M; Kuerban A; Liu H; Dong Y; Cai Q; Ma M; Wu X
Cell Death Dis; 2023 Apr; 14(4):280. PubMed ID: 37080972
[TBL] [Abstract][Full Text] [Related]
40. RhoA/ROCK1 signaling regulates stress granule formation and apoptosis.
Tsai NP; Wei LN
Cell Signal; 2010 Apr; 22(4):668-75. PubMed ID: 20004716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
